CELG-RT
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 5225 |  ANL Adlai Nortye Ltd - American Depositary Shares | 13.40 USD | -5.57% | -2.05% | +3.08% | +674.57% | 0 USD | ||
| 5296 |  NVO Novo Nordisk A/S | 45.27 USD | -0.13% | -6.12% | -3.86% | -20.24% | 0 USD | ||
| 6334 |  ADAP Adaptimmune Therapeutics plc - American Depositary Shares | 0.05 USD | 0.00% | 0.00% | -61.54% | -16.67% | 0 USD | ||
| 6337 |  AADI Aadi Bioscience Inc | 2.05 USD | 0.00% | 0.00% | -19.29% | -27.30% | 0 USD |
Frequently asked questions about Bristol-Myers Squibb Company Celegne Contingent Value Rights
What is the Bristol-Myers Squibb Company Celegne Contingent Value Rights stock price today?
The current price of Bristol-Myers Squibb Company Celegne Contingent Value Rights (CELG-RT) is 0.1285. Over the past 24 hours, the stock has changed by +7.17%. Follow the CELG-RT chart for real-time price dynamics.
What is the stock ticker of Bristol-Myers Squibb Company Celegne Contingent Value Rights?
Bristol-Myers Squibb Company Celegne Contingent Value Rights trades under the ticker CELG-RT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Bristol-Myers Squibb Company Celegne Contingent Value Rights stock going up?
CELG-RT has changed by +7.26% over the last week, +39.52% over the last month, and +231.19% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Bristol-Myers Squibb Company Celegne Contingent Value Rights?
Bristol-Myers Squibb Company Celegne Contingent Value Rights currently has a market capitalization of 0. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
How can I buy Bristol-Myers Squibb Company Celegne Contingent Value Rights stock?
You can buy Bristol-Myers Squibb Company Celegne Contingent Value Rights (CELG-RT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Bristol-Myers Squibb Company Celegne Contingent Value Rights stock?
Investing in Bristol-Myers Squibb Company Celegne Contingent Value Rights requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CELG-RT chart and related analysis on metatrader.com as part of your research.